These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28889268)

  • 21. Iron and aluminum homeostasis in neural disorders.
    Joshi JG; Dhar M; Clauberg M; Chauthaiwale V
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):207-13. PubMed ID: 7843099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease.
    Becaria A; Bondy SC; Campbell A
    J Alzheimers Dis; 2003 Feb; 5(1):31-8. PubMed ID: 12590164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative binding study of aluminum and chromium to human transferrin. Effect of iron.
    Moshtaghie AA; Ani M; Bazrafshan MR
    Biol Trace Elem Res; 1992; 32():39-46. PubMed ID: 1375080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The toxicology of aluminum in the brain: a review.
    Yokel RA
    Neurotoxicology; 2000 Oct; 21(5):813-28. PubMed ID: 11130287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminum forms in drinking water and risk of Alzheimer's disease.
    Gauthier E; Fortier I; Courchesne F; Pepin P; Mortimer J; Gauvreau D
    Environ Res; 2000 Nov; 84(3):234-46. PubMed ID: 11097797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aluminum as a toxicant.
    Becaria A; Campbell A; Bondy SC
    Toxicol Ind Health; 2002 Aug; 18(7):309-20. PubMed ID: 15068131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of aluminum and copper on neuroinflammation and Alzheimer's disease.
    Campbell A
    J Alzheimers Dis; 2006 Nov; 10(2-3):165-72. PubMed ID: 17119285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin-gallium binding in Alzheimer's disease.
    Lancet; 1991 Nov; 338(8779):1394-6. PubMed ID: 1682757
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer's disease.
    Dey M; Singh RK
    Pharmacol Rep; 2022 Jun; 74(3):439-450. PubMed ID: 35088386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competition of iron and aluminum for transferrin: the molecular basis for aluminum deposition in iron-overloaded dialysis patients?
    Van Landeghem GF; D'Haese PC; Lamberts LV; De Broe ME
    Exp Nephrol; 1997; 5(3):239-45. PubMed ID: 9208284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic studies on the removal of iron and aluminum from recombinant and site-directed mutant N-lobe half transferrins.
    Li Y; Harris WR; Maxwell A; MacGillivray RT; Brown T
    Biochemistry; 1998 Oct; 37(40):14157-66. PubMed ID: 9760252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration.
    Bondy SC
    Toxicology; 2014 Jan; 315():1-7. PubMed ID: 24189189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.
    Yumoto S; Kakimi S; Ohsaki A; Ishikawa A
    J Inorg Biochem; 2009 Nov; 103(11):1579-84. PubMed ID: 19744735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease.
    Giambattistelli F; Bucossi S; Salustri C; Panetta V; Mariani S; Siotto M; Ventriglia M; Vernieri F; Dell'acqua ML; Cassetta E; Rossini PM; Squitti R
    Neurobiol Aging; 2012 Aug; 33(8):1633-41. PubMed ID: 21514009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum involvement in the progression of Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2013; 35(1):7-43. PubMed ID: 23380995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurotoxicity of environmental aluminum is still an issue.
    Bondy SC
    Neurotoxicology; 2010 Sep; 31(5):575-81. PubMed ID: 20553758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure to Aluminum in Daily Life and Alzheimer's Disease.
    Nie J
    Adv Exp Med Biol; 2018; 1091():99-111. PubMed ID: 30315451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation.
    Crespo ÂC; Silva B; Marques L; Marcelino E; Maruta C; Costa S; Timóteo A; Vilares A; Couto FS; Faustino P; Correia AP; Verdelho A; Porto G; Guerreiro M; Herrero A; Costa C; de Mendonça A; Costa L; Martins M
    Neurobiol Aging; 2014 Apr; 35(4):777-85. PubMed ID: 24199959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron genes, iron load and risk of Alzheimer's disease.
    Lehmann DJ; Worwood M; Ellis R; Wimhurst VL; Merryweather-Clarke AT; Warden DR; Smith AD; Robson KJ
    J Med Genet; 2006 Oct; 43(10):e52. PubMed ID: 17047092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.